Comparing Immediate Removal and Postoperative 1 Day of Urinary Catheter After Colorectal Cancer Surgery
Launched by SEOUL ST. MARY'S HOSPITAL · Jan 8, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study aims to demonstrate that removing the urinary drain immediately after colorectal cancer surgery is non-inferior to removing it on the first day (within 24 hours) after surgery in terms of the incidence of acute urinary retention.
To evaluate the non-inferiority of the incidence of acute urinary retention (AUR) according to the timing of urinary drain removal after surgery.
Secondary outcomes are the incidence of symptomatic urinary tract infection (UTI), postvoid residual (PVR), length of hospital stay, postoperative pain score, and narcotic analgesic usage, early ambulation su...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 19 years old 80 years old
- • Patients diagnosed with colorectal cancer who are eligible for radical resection surgery
- • Patients who underwent open, laparoscopic, or robotic surgery
- • Written informed consent
- Exclusion Criteria:
- • Patients who have undergone two or more major abdominal surgeries, including lateral pelvic lymph node dissection, at the same time
- • Patients who require continuous monitoring through a urinary catheter due to hemodynamic instability or massive bleeding, etc.
- • Patients who have undergone conventional treatment in cases other than distant metastasis or R0 resection
- • Patients who have developed complications related to the urinary system during surgery and require maintenance of a urinary catheter such as a urethral stent
- • Patients who have undergone urinary surgery such as urethral stent placement, cystectomy, or urostomy in the past
- • Patients who are on hemodialysis or peritoneal dialysis due to chronic renal failure
- • Patients who cannot participate in a clinical trial at the discretion of a physician
- • Patients who do not wish to participate in the study
About Seoul St. Mary's Hospital
Seoul St. Mary's Hospital, a leading healthcare institution in South Korea, is dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Affiliated with the Catholic University of Korea, the hospital combines state-of-the-art facilities with a commitment to high-quality patient care and ethical research practices. With a multidisciplinary team of experienced researchers and clinicians, Seoul St. Mary's Hospital actively participates in a wide range of clinical studies, focusing on diverse therapeutic areas to contribute valuable insights to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported